Calliditas Therapeutics Pink Sheet Forecast - Accumulation Distribution
| CLTEF Stock | USD 0.55 0.01 1.85% |
Calliditas Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Calliditas Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Calliditas |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 18.18 | 0.0182 |
| Check Calliditas Therapeutics Volatility | Backtest Calliditas Therapeutics | Information Ratio |
Calliditas Therapeutics Trading Date Momentum
| On December 26 2025 Calliditas Therapeutics AB was traded for 0.55 at the closing time. The highest daily price throughout the period was 0.55 and the lowest price was 0.54 . There was no trading activity during the period 0.0. Lack of trading volume on 12/26/2025 did not affect price variability. The overall trading delta to current closing price is 1.82% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Calliditas Therapeutics to competition
Calliditas Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calliditas Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Calliditas Therapeutics could also be used in its relative valuation, which is a method of valuing Calliditas Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Calliditas Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Calliditas Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Calliditas Therapeutics shares will generate the highest return on investment. By undertsting and applying Calliditas Therapeutics pink sheet market strength indicators, traders can identify Calliditas Therapeutics AB entry and exit signals to maximize returns.
Calliditas Therapeutics Risk Indicators
The analysis of Calliditas Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Calliditas Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting calliditas pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3336.92 | |||
| Standard Deviation | 9810.24 | |||
| Variance | 9.624086944E7 | |||
| Downside Variance | 1006.94 | |||
| Semi Variance | (1,253) | |||
| Expected Short fall | (8,121) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Calliditas Pink Sheet
Calliditas Therapeutics financial ratios help investors to determine whether Calliditas Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Calliditas with respect to the benefits of owning Calliditas Therapeutics security.